copy of dr. willmott on mechanisms of resistance in ovarian cancer
Published 6 years ago • 32 plays • Length 0:22Download video MP4
Download video MP3
Similar videos
-
1:02
dr. willmott on mechanisms of resistance in ovarian cancer
-
0:40
dr. willmott on fda approval of maintenance olaparib in ovarian cancer
-
0:12
copy of dr. mccann on resistance mutations in ovarian cancer
-
7:27
parp inhibitor mechanisms of resistance
-
1:30
dr. mirza on the evolving treatment landscape in recurrent ovarian cancer
-
0:57
dr. westin on parp resistance in ovarian cancer
-
0:13
copy of dr. karam on primary debulking surgery versus neoadjuvant chemotherapy in ovarian cancer
-
1:13
dr. mccann on resistance mutations in ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
0:49
dr. comerci on the use of laparoscopy in ovarian cancer
-
2:02
dr. konecny on resistance to parp inhibitors in ovarian cancer
-
1:15
dr. birrer on fda approval of rucaparib in ovarian cancer
-
1:40
dr. burger on the toxicity profile of bevacizumab in ovarian cancer
-
1:14
dr. lewin on the addition of hipec to interval cytoreductive surgery in ovarian cancer
-
0:59
dr. campos on next steps with parp inhibitors in ovarian cancer
-
4:00
timing of oophorectomy in ovarian cancer
-
14:46
managing platinum-resistant ovarian cancer
-
2:14
dr. markman on timing of bso in patients with ovarian cancer
-
0:16
copy of dr. monk on the fda approval of maintenance rucaparib in ovarian cancer